Jeff Geschwind, MD is at the forefront of targeting cancer's energy source. His research at Cage Pharma into inhibiting glycolysis aims to disrupt tumor growth and create powerful new treatment options. https://sciprofiles.com/profile/2296312?utm_source=mdpi.com&utm_medium=website&utm_campaign=avatar_name